Personalized medicine in psychiatry: problems and promises

被引:173
|
作者
Ozomaro, Uzoezi [1 ]
Wahlestedt, Claes [1 ,2 ,3 ]
Nemeroff, Charles B. [1 ,2 ,3 ]
机构
[1] Univ Miami, Leonard M Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Ctr Therapeut Innovat, Miami, FL 33136 USA
[3] Univ Miami, Leonard M Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL USA
来源
BMC MEDICINE | 2013年 / 11卷
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
Major depressive disorder; Schizophrenia; Personalized medicine; Psychiatric hereditability; Epigenetics; Environmental factors; Endophenotypes; Pharmacogenomics; Neuroimaging genetics; CORTICOTROPIN-RELEASING-FACTOR; SEROTONIN TRANSPORTER GENE; GENOME-WIDE ASSOCIATION; INDUCED WEIGHT-GAIN; SINGLE NUCLEOTIDE POLYMORPHISM; MAJOR DEPRESSIVE DISORDER; FAMILY-BASED ASSOCIATION; 5-HT2A RECEPTOR GENE; CLOZAPINE-INDUCED AGRANULOCYTOSIS; ABNORMAL INVOLUNTARY MOVEMENTS;
D O I
10.1186/1741-7015-11-132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The central theme of personalized medicine is the premise that an individual's unique physiologic characteristics play a significant role in both disease vulnerability and in response to specific therapies. The major goals of personalized medicine are therefore to predict an individual's susceptibility to developing an illness, achieve accurate diagnosis, and optimize the most efficient and favorable response to treatment. The goal of achieving personalized medicine in psychiatry is a laudable one, because its attainment should be associated with a marked reduction in morbidity and mortality. In this review, we summarize an illustrative selection of studies that are laying the foundation towards personalizing medicine in major depressive disorder, bipolar disorder, and schizophrenia. In addition, we present emerging applications that are likely to advance personalized medicine in psychiatry, with an emphasis on novel biomarkers and neuroimaging.
引用
收藏
页数:35
相关论文
共 50 条
  • [41] Personalized genomic medicine
    Giuseppe Novelli
    Internal and Emergency Medicine, 2010, 5 : 81 - 90
  • [42] Personalized medicine 2011
    Blum, H. E.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (10) : 459 - 460
  • [43] Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases
    Tavakolpour, S.
    Darvishi, M.
    Ghasemiadl, M.
    CLINICAL GENETICS, 2018, 93 (03) : 481 - 497
  • [44] Neuroscience in Psychiatry towards an integrative and personalized medicine in the DSM-V: a proposal
    Novo Olivas, Carlos Augusto
    Perez Solis, Erick Emmanuel
    CUADERNOS DE NEUROPSICOLOGIA-PANAMERICAN JOURNAL OF NEUROPSYCHOLOGY, 2009, 3 (01): : 65 - 103
  • [45] Establishing infrastructure in Personalized Medicine: The University of Maryland Program for Personalized and Genomic Medicine
    Shuldiner, A. R.
    Pakyz, R. E.
    Palmer, K.
    Maloney, K. A.
    Doyle, L.
    McArdle, P. F.
    Horenstein, R. B.
    Pollin, T., I
    Beitelshees, A. L.
    Overby, C. L.
    Schub, J.
    O'Neill, C.
    Bhatty, S.
    Alestock, T. D.
    Bone, Jeng L. J.
    Brown, L.
    Kelemen, M. D.
    Robinson, S. W.
    Vesely, M. R.
    Zhao, R. Y.
    Ambulos, N.
    Blitzer, M. G.
    PROCEEDINGS OF THE 2ND INTERNATIONAL CONGRESS ON PERSONALIZED MEDICINE (UPCP 2013), 2014, : 41 - 46
  • [46] Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice
    Squassina, Alessio
    Manchia, Mirko
    Manolopoulos, Vangelis G.
    Artac, Mehmet
    Lappa-Manakou, Christina
    Karkabouna, Sophia
    Mitropoulos, Konstantinos
    Del Zompo, Maria
    Pantrinos, George P.
    PHARMACOGENOMICS, 2010, 11 (08) : 1149 - 1167
  • [47] Empowering Personalized Medicine with Big Data and Semantic Web Technology: Promises, Challenges, and Use Cases
    Panahiazar, Maryam
    Taslimitehrani, Vahid
    Jadhav, Ashutosh
    Pathak, Jyotishman
    2014 IEEE INTERNATIONAL CONFERENCE ON BIG DATA (BIG DATA), 2014, : 790 - 795
  • [48] Problems and methods in health care economics: is personalized medicine an exception?
    Sickinger, Sabine
    Payne, Katherine
    Rogowski, Wolf
    ETHIK IN DER MEDIZIN, 2013, 25 (03) : 267 - 275
  • [49] Personalized medicine: Prediction of disease vulnerability in mood disorders
    Prendes-Alvarez, Stefania
    Nemeroff, Charles B.
    NEUROSCIENCE LETTERS, 2018, 669 : 10 - 13
  • [50] Why personalized medicine will fail if we stay the course
    Ramos, Edward
    Callier, Shawneequa L.
    Rotimi, Charles N.
    PERSONALIZED MEDICINE, 2012, 9 (08) : 839 - 847